Completed PHASE3 INTERVENTIONAL 2-arm NCT00291499

Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand

Clinical Evaluation of Condrosulf 800 mg in the Treatment of Symptomatic OA of the Hand: a 6-month, Double-blind, Placebo Controlled Study

Sponsor: IBSA Institut Biochimique SA

Conditions Osteoarthrosis

Interventions Chondroitin 4&6 sulfate (Condrosulf) Placebo

Updated 6 times since 2017 Last updated: Feb 11, 2021 Started: Jun 30, 2005 Primary completion: Dec 31, 2009 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Osteoarthrosis, this trial is completed. The trial is conducted by IBSA Institut Biochimique SA and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Apr 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IBSA Institut Biochimique SA

Data source: IBSA Institut Biochimique SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.